⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5726524 | 0.88 | — | — | |
| SCHEMBL892131 | 0.85 | — | — | |
| SCHEMBL756797 | 0.73 | — | — | |
| SCHEMBL11844840 | 0.71 | — | — | |
| SCHEMBL10530709 | 0.71 | — | — | |
| SCHEMBL9847365 | 0.71 | — | — | |
| SCHEMBL5093847 | 0.66 | — | — | |
| SCHEMBL11630889 | 0.61 | — | — | |
| SCHEMBL1056660 | 0.61 | — | — | |
| SCHEMBL12304972 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11925690-B2 | Bifunctional molecules for targeting Rpn11 | AMPHISTA THERAPEUTICS LIMITED (GB) | 2024-03-12 | — | — | US | disclosed |
| EP-3063154-B1 | CROSS-COUPLING OF UNACTIVATED SECONDARY BORONIC ACIDS | UNIV ILLINOIS (US) | 2023-08-30 | — | — | EP | disclosed |
| US-20220313656-A1 | NEW CLASS OF ANTIBIOTICS HAVING LOW MIC-VALUES TOWARDS DIFFERENT STRAINS OF BACTERIA | Københavns Universitet (DK) | 2022-10-06 | — | — | US | disclosed |
| US-20210283139-A1 | BIFUNCTIONAL MOLECULES FOR TARGETING UCHL5 | AMPHISTA THERAPEUTICS LIMITED (GB) | 2021-09-16 | — | — | US | disclosed |
| US-11005108-B2 | Molecularly tunable heterogeneous catalysts by edge functionalization of graphitic carbons | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-05-11 | — | — | US | disclosed |
| EP-3807263-A1 | BIFUNCTIONAL MOLECULES FOR TARGETING UCHL5 | Amphista Therapeutics Ltd (GB) | 2021-04-21 | — | — | EP | disclosed |
| EP-3807272-A1 | BIFUNCTIONAL MOLECULES FOR TARGETING RPN11 | Amphista Therapeutics Ltd (GB) | 2021-04-21 | — | — | EP | disclosed |
| CN-112585127-A | Bifunctional molecules for targeting Uchl5 | 安菲斯塔治疗有限责任公司 | 2021-03-30 | — | — | CN | disclosed |
| CN-112533918-A | Bifunctional molecules for targeting Rpn11 | 安菲斯塔治疗有限责任公司 | 2021-03-19 | — | — | CN | disclosed |
| US-20210009508-A1 | Automated Synthesis of Small Molecules Using Chiral, Non-Racemic Boronates | NATIONAL SCIENCE FOUNDATION | 2021-01-14 | — | — | US | disclosed |
| EP-1689405-B1 | THIORIDAZINE AND DERIVATIVES THEREOF FOR REVERSING ANTI-MICROBIAL DRUG-RESISTANCE | NOA SIC APS (DK) | 2011-11-09 | — | — | EP | disclosed |
| US-7741352-B2 | KCNQ channel modulating compounds and their pharmaceutical use | NEUROSEARCH A/S (DK) | 2010-06-22 | — | — | US | disclosed |
| US-20090292024-A1 | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-11-26 | — | — | US | disclosed |
| EP-1908466-A1 | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Daiichi Sankyo Company, Limited (JP) | 2008-04-09 | — | — | EP | disclosed |
| US-20070287702-A1 | Thioridazine And Derivatives Thereof For Reversing Anti-Microbial Drug-Resistance | NOA SIC APS (DK) | 2007-12-13 | — | — | US | disclosed |
| EP-1689405-A1 | THIORIDAZINE AND DERIVATIVES THEREOF FOR REVERSING ANTI-MICROBIAL DRUG-RESISTANCE | Kobenhavns Universitet (DK) | 2006-08-16 | — | — | EP | disclosed |
| US-20060173058-A1 | Kcnq channel modulating compounds and their pharmaceutical use | NEUROSEARCH A/S (DK) | 2006-08-03 | — | — | US | disclosed |
| EP-1603858-A2 | KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE | NeuroSearch A/S (DK) | 2005-12-14 | — | — | EP | disclosed |
| WO-2005046694-A1 | THIORIDAZINE AND DERIVATIVES THEREOF FOR REVERSING ANTI-MICROBIAL DRUG-RESISTANCE | Københavns Universitet (DK) | 2005-05-26 | — | — | WO | disclosed |
| WO-2004080377-A2 | KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE | NEUROSEARCH A/S (DK) | 2004-09-23 | — | — | WO | disclosed |